| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/20/2011 | EP2311492A1 Antibody-containing stabilized preparations |
| 04/20/2011 | EP2311491A1 Composition comprising an antibody against macrophage colony-stimulating factor (M-CSF) and a chelating agent |
| 04/20/2011 | EP2311490A2 Uses of antibodies to aminophospholipids for cancer treatment |
| 04/20/2011 | EP2311489A2 Formulation of antibody-containing solutions comprising a sugar as a stabilizer |
| 04/20/2011 | EP2311488A2 Vaccine composition |
| 04/20/2011 | EP2311487A2 Identification of surface-associated antigens for tumour diagnosis and therapy |
| 04/20/2011 | EP2311485A1 Thymosin beta 4 promotes wound repair |
| 04/20/2011 | EP2311484A1 Use of IL-12 and IL-12 antagonists for the manufacture of a pharmaceutical composition for the treatment of autoimmune diseases |
| 04/20/2011 | EP2311481A2 Treatment of demyelinating disorders with soluble lymphotoxin-beta-receptor |
| 04/20/2011 | EP2311470A1 Method for simultaneous induction of ctl and t cell |
| 04/20/2011 | EP2311468A1 Gene overexpressed in cancer |
| 04/20/2011 | EP2311436A1 Stabilized protein crystals, formulations containing them and methods of making them |
| 04/20/2011 | EP2310526A2 Compositions for the detection and treatment of colorectal cancer |
| 04/20/2011 | EP2310417A1 Oxidized ldl specific antibody-fusion and conjugated proteins |
| 04/20/2011 | EP2310416A1 Anti-gd2 antibodies and methods and uses related thereto |
| 04/20/2011 | EP2310412A2 Immunoglobulins with reduced aggregation |
| 04/20/2011 | EP2310049A1 Prostaglandin e2 binding proteins and uses thereof |
| 04/20/2011 | EP2310048A1 Stabilizer and vaccine composition comprising one or more live attenuated flaviviruses |
| 04/20/2011 | EP2310047A1 Globo h and related anti-cancer vaccines with novel glycolipid adjuvants |
| 04/20/2011 | EP2310046A2 Novel adjuvant compositions |
| 04/20/2011 | EP2310045A1 Rapid responses to delayed booster immunisations |
| 04/20/2011 | EP2310006A2 Treating cancer |
| 04/20/2011 | EP1899487B1 Gfats as modifiers of the axin pathway and methods of use |
| 04/20/2011 | EP1874312B1 Treatment of hpv induced anogenital intraepithelial neoplasia |
| 04/20/2011 | EP1859793B1 Novel combinational use of a sulfonamide compound in the treatment of cancer |
| 04/20/2011 | EP1680140B1 Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof |
| 04/20/2011 | EP1670926B1 Modified cea /b7 vector |
| 04/20/2011 | EP1624892B1 Therapeutic use of anti-cs1 antibodies |
| 04/20/2011 | EP1578361B1 Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence |
| 04/20/2011 | EP1529063B1 Antibodies anti-c5 component of the complement system and their use |
| 04/20/2011 | EP1427826B1 HIV- RT-nef-Gag codon optimised DNA vaccines |
| 04/20/2011 | EP1385993B1 Method of detecting and treating tuberous sclerosis complex associated disorders |
| 04/20/2011 | EP1224461B1 Reagents and methods for diagnosing, imaging and treating atherosclerotic disease |
| 04/20/2011 | CN1964737B Methods of using IL-1 antagonists to treat autoinflammatory disease |
| 04/20/2011 | CN1849395B HLA-a24 binding cancer antigen peptide derived from ribin |
| 04/20/2011 | CN1701117B Antibody against enzyme specifically cleaving VON WILLEBRAND factor and assay system using the same |
| 04/20/2011 | CN1628179B Detection of hepatocellular carcinoma |
| 04/20/2011 | CN102027123A Recombinant production of authentic human proteins using human cell expression systems |
| 04/20/2011 | CN102027020A Recombinant chimeric antigens for diagnosis and prevention of scrub typhus |
| 04/20/2011 | CN102027018A Agent for treating disease |
| 04/20/2011 | CN102027017A Agent for treating disease |
| 04/20/2011 | CN102027016A Agent for treating disease |
| 04/20/2011 | CN102027015A Anti-CXCR4 antibodies |
| 04/20/2011 | CN102027014A Novel antibodies used to treat cancer |
| 04/20/2011 | CN102027013A Humanized antibodies specific for amino acid sequence RGD of an extracellular matrix protein and the uses thereof |
| 04/20/2011 | CN102027011A Anti-human IL-21 monoclonal antibodies |
| 04/20/2011 | CN102026672A C2ORF18 as target gene for cancer therapy and diagnosis |
| 04/20/2011 | CN102026660A Methods of treatment |
| 04/20/2011 | CN102026659A Method for the prevention and treatment of cancer by inhibition of GPVI |
| 04/20/2011 | CN102026658A Improved immunizing composition |
| 04/20/2011 | CN102026657A Vaccines for malaria |
| 04/20/2011 | CN102026634A Induction of tumor hypoxia for cancer therapy |
| 04/20/2011 | CN102021184A Antigenic polypeptides |
| 04/20/2011 | CN102021153A Human telomerase catalytic subunit |
| 04/20/2011 | CN102021149A Gene NSI deficit type respiratory syncytial virus and application thereof to treating lung cancer |
| 04/20/2011 | CN102021148A Gene NS1 (Structural Protein) defective respiratory syncytial virus and application thereof |
| 04/20/2011 | CN102021146A West nile virus NS1 protein monoclonal antibody, identified B cell epitope thereof and application |
| 04/20/2011 | CN102021124A Surface display and application of yeast of white spot syndrome virus (WSSV) VP37 |
| 04/20/2011 | CN102018964A Three-plasmid co-immune vaccine system capable of breaking immune tolerance and preparation method thereof |
| 04/20/2011 | CN102018958A Method for removing hybrid protein and host DNA from vaccine product |
| 04/20/2011 | CN102018957A Production method of hog cholera live vaccine |
| 04/20/2011 | CN102018956A F-gene type attenuated live mumps vaccine and preparation method and application thereof |
| 04/20/2011 | CN102018955A Purification method for producing viral vaccine in large scale |
| 04/20/2011 | CN101629159B Brucella abortus recombinant strain and application thereof |
| 04/20/2011 | CN101555477B Heavy and light chain variable region gene of monoclonal antibody resisting human amyloid protein, and its uses |
| 04/20/2011 | CN101538550B Helicobacter pylori viable bacteria vector vaccine and special recombination bacteria thereof |
| 04/20/2011 | CN101475921B Attenuated pseudomonas fluorescens and use thereof |
| 04/20/2011 | CN101401934B T cell component vaccine for preventing and/or treating immune correlated diseases |
| 04/20/2011 | CN101355964B Immunoadjuvant |
| 04/20/2011 | CN101155833B Separation of contaminants from streptococcus pneumoniae polysaccharide by ph manipulation |
| 04/19/2011 | US7928213 Nucleic acids encoding chimeric CD154 polypeptides |
| 04/19/2011 | US7928205 Methods for refolding of recombinant antibodies |
| 04/19/2011 | US7928201 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 04/19/2011 | US7928196 Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer |
| 04/19/2011 | US7928194 Recombinant antigen for diagnosis and prevention of murine typhus |
| 04/19/2011 | US7928192 ADP-ribosylating bacterial toxins |
| 04/19/2011 | US7928187 Neuropeptide alarin |
| 04/19/2011 | US7928074 Using interleukin-1 specfic immunoglobulin fusion and tumor necrosis factor inhibitors to treat inflammatory and/or autoimmune disorders |
| 04/19/2011 | US7928073 Purified polypeptides having IL-13 receptor activity |
| 04/19/2011 | US7928071 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 04/19/2011 | US7928061 Endothelial growth factor; isolated polypeptide; stimulates cell proliferation, neovascularization, vascular system permeability; uses thereof in medical and diagnostic applications |
| 04/19/2011 | US7927870 DNA vaccine formulations |
| 04/19/2011 | US7927858 Drying process |
| 04/19/2011 | US7927835 Expression vector comprising nucleotide sequences coding bone morphogenic protein/selectin fusion for use in treatment and prvention of inflammatory diseases |
| 04/19/2011 | US7927834 Recombinant production of mixtures of antibodies |
| 04/19/2011 | US7927833 Composition and method for enhancing immune response |
| 04/19/2011 | US7927806 Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues |
| 04/19/2011 | US7927622 Methods of transnasal transport/immunization with highly adaptable carriers |
| 04/19/2011 | US7927612 Combinations and methods for treating neoplasms |
| 04/19/2011 | US7927609 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 04/19/2011 | US7927608 Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications |
| 04/19/2011 | US7927607 S. agalactiae antigens I and II |
| 04/19/2011 | US7927606 Modified free-living microbes, vaccine compositions and methods of use thereof |
| 04/19/2011 | US7927605 Diagnosing and preventing microorganismal infections using iron-restricted conditions; genetic vaccines |
| 04/19/2011 | US7927603 Recombinant fusion-enzyme with repair activity on DNA lesions produced by UV radiation; its usage, preparation and purification method; a method to stabilize enzymes and treatment methods |
| 04/19/2011 | US7927602 Chimeric proteins comprising death domains fused to biotin-streptavidin binding pairs, administered for prophylaxis of asthma, allergies, poisoning, autoimmune or graft versus host disease |
| 04/19/2011 | US7927600 Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compound |
| 04/19/2011 | US7927599 Chondrocyte therapeutic delivery system |
| 04/19/2011 | US7927598 Broad-spectrum δ-endotoxins and method and kit for detecting same and for detecting polynucleotides encoding same |
| 04/19/2011 | US7927597 Proteins, polynucleotides, antibodies, transgenic animals, hybridoma; tissue specific expression; pancreatic |